Publication details

Přínos intravitreální aplikace anti - VEGF preparátů v léčbě prahového stadia ROP 3+ v zóně I-II: Výsledky čtyřleté studie

Title in English Effects of Intravitreal pegaptanib or Bevacizumab and Laser in Treatment of Threshold Retinopathy of Prematurity in Zone I and Posterior Zone II - Four Years Results.
Authors

AUTRATA Rudolf ŠENKOVÁ Kateřina HOLOUŠOVÁ Marie KREJČÍŘOVÁ Inka DOLEŽEL Zdeněk BOREK Ivo

Year of publication 2012
Type Article in Periodical
Magazine / Source Česká a slovenská oftalmologie
MU Faculty or unit

Faculty of Medicine

Citation
Field ORL, ophthalmology, stomatology
Keywords retinopathy of prematurity; stage 3+; zone I; posterior zone II; anti-vascular endothelial growth factor therapy; pegaptanib (Macugen); bevacizumab (Avastin); intravitreal injections; RetCam photography
Description To evaluate efficacy and safety of intravitreal injection of pagaptanib or bevacizumab and laser photocoagulation for treatment of threshold stage 3+ retinopathy of prematurity (ROP) affecting zone I and posterior zone II, and to compare the results in terms of regression, development of peripheral retinal vessels with conventional laser photocoagulation or combined with cryotherapy.

You are running an old browser version. We recommend updating your browser to its latest version.

More info